Calendar

Week of Nov 24, 2025

Nov 25, 2025approval278d agoPERAMPANEL — FDA approvalPERAMPANEL

Sponsor: MSN. Form: TABLET. Route: ORAL

Nov 25, 2025grant278d agoLAUREATE INSTITUTE FOR BRAIN RESEARCH — Mechanisms of Low-Intensity Focused Ultrasound Neuromodulation for Post-Traum...

GM grant. $431,302. PI: Adrienne A Taren

Nov 26, 2025approval277d agoVALBENAZINE TOSYLATE — FDA approvalVALBENAZINE TOSYLATE

Sponsor: ZYDUS LIFESCIENCES. Form: CAPSULE. Route: ORAL

Nov 26, 2025approval277d agoDALBAVANCIN HYDROCHLORIDE — FDA approvalFresenius Kabi USA LLC

Sponsor: KINDOS. Form: POWDER. Route: INTRAVENOUS

Nov 26, 2025approval277d agoCABENUVA KIT (CABOTEGRAVIR) — FDA approvalViiV Healthcare Company

Sponsor: VIIV HLTHCARE. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

Nov 28, 2025approval275d agoEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalEPYSQLI

Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTION. Route: SOLUTION

Nov 28, 2025approval275d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

Nov 28, 2025approval275d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

Nov 28, 2025approval275d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: HIKMA. Form: TABLET. Route: ORAL

Nov 28, 2025approval275d agoCYCLOSPORINE — FDA approvalRestasis

Sponsor: AMNEAL. Form: EMULSION. Route: OPHTHALMIC

Nov 28, 2025approval275d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalPrinston Pharmaceutical Inc

Sponsor: UNICHEM. Form: TABLET. Route: ORAL

Nov 28, 2025approval275d agoARMLUPEG (PEGFILGRASTIM-UNNE) — FDA approvalARMLUPEG

Sponsor: LUPIN LTD. Form: INJECTION. Route: SOLUTION

Dec 1, 2025approval272d agoCEFAZOLIN SODIUM — FDA approvalSamson Medical Technologies LLC

Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

Dec 1, 2025approval

page 392 of 475